← Open Payments lookup

JOHN TILMON: Open Payments

NPI 1619903721 · STERLINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$968 in 41 payments from 15 companies in 2025. Trend: 2023 $453 · 2024 $663 · 2025 $968

Food & beverage: $912Education: $56
CompanyPaymentsAmount
ABBVIE INC.13$253
Bayer Healthcare Pharmaceuticals Inc.7$155
Ardelyx, Inc.1$114
Otsuka America Pharmaceutical, Inc.3$86
Novo Nordisk Inc3$57
Teva Pharmaceuticals USA, Inc.2$51
Neurocrine BioSciences, Inc.2$46
Astellas Pharma US Inc2$41
Boehringer Ingelheim Pharmaceuticals, Inc.1$33
Abbott Laboratories2$30

Products named: Kerendia, IBSRELA, QULIPTA, UBRELVY, REXULTI, VRAYLAR, AUSTEDO XR, INGREZZA.

Industry payments across LA — which companies pay providers there.